Wilhelm O G, Jaskunas S R, Vlahos C J, Bang N U
Lilly Laboratory for Clinical Research, Eli Lilly and Company, Indianapolis, Indiana.
J Biol Chem. 1990 Aug 25;265(24):14606-11.
The kringle-2 domain (residues 176-262) of tissue-type plasminogen activator (t-PA) was cloned and expressed in Escherichia coli. The recombinant peptide, which concentrated in cytoplasmic inclusion bodies, was isolated, solubilized, chemically refolded, and purified by affinity chromatography on lysine-Sepharose to apparent homogeneity. [35S]Cysteine-methionine-labeled polypeptide was used to study the interactions of kringle-2 with lysine, fibrin, and plasminogen activator inhibitor-1. The kringle-2 domain bound to lysine-Sepharose and to preformed fibrin with a Kd = 104 +/- 6.2 microM (0.86 +/- 0.012 binding site) and a Kd = 4.2 +/- 1.05 microM (0.80 +/- 0.081 binding site), respectively. Competition experiments and direct binding studies showed that the kringle-2 domain is required for the formation of the ternary t-PA-plasminogen-intact fibrin complex and that the association between the t-PA kringle-2 domain and fibrin does not require plasmin degradation of fibrin and exposure of new COOH-terminal lysine residues. We also observed that kringle-2 forms a complex with highly purified guanidine-activated plasminogen activator inhibitor-1, dissociable by 0.2 M epsilon-aminocaproic acid. The kringle-2 polypeptide significantly inhibited tissue plasminogen activator/plasminogen activator inhibitor-1 interaction. The kringle-2 domain bound to plasminogen activator inhibitor-1 in a specific and saturable manner with a Kd = 0.51 +/- 0.055 microM (0.35 +/- 0.026 binding site). Therefore, the t-PA kringle-2 domain is important for the interaction of t-PA not only with fibrin, but also with plasminogen activator inhibitor-1 and thus represents a key structure in the regulation of fibrinolysis.
组织型纤溶酶原激活剂(t-PA)的kringle-2结构域(第176 - 262位氨基酸残基)在大肠杆菌中进行克隆和表达。该重组肽聚集在细胞质包涵体中,经分离、溶解、化学重折叠,并通过赖氨酸 - 琼脂糖亲和层析纯化至表观均一性。用[35S]半胱氨酸 - 甲硫氨酸标记的多肽研究kringle-2与赖氨酸、纤维蛋白和纤溶酶原激活剂抑制剂-1的相互作用。kringle-2结构域与赖氨酸 - 琼脂糖和预先形成的纤维蛋白结合,解离常数(Kd)分别为104±6.2微摩尔(0.86±0.012个结合位点)和4.2±1.05微摩尔(0.80±0.081个结合位点)。竞争实验和直接结合研究表明,kringle-2结构域是形成t-PA - 纤溶酶原 - 完整纤维蛋白三元复合物所必需的,并且t-PA kringle-2结构域与纤维蛋白之间的结合不需要纤维蛋白经纤溶酶降解以及新的COOH末端赖氨酸残基的暴露。我们还观察到kringle-2与高度纯化的胍激活的纤溶酶原激活剂抑制剂-1形成复合物,可被0.2Mε-氨基己酸解离。kringle-2多肽显著抑制组织纤溶酶原激活剂/纤溶酶原激活剂抑制剂-1的相互作用。kringle-2结构域以特异性和可饱和的方式与纤溶酶原激活剂抑制剂-1结合,解离常数(Kd)为0.51±0.055微摩尔(0.35±0.026个结合位点)。因此,t-PA kringle-2结构域不仅对t-PA与纤维蛋白的相互作用很重要,而且对t-PA与纤溶酶原激活剂抑制剂-1的相互作用也很重要,因此代表了纤维蛋白溶解调节中的关键结构。